Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer | Zendy

Asim Afaq | Zendy; Jamshed Bomanji | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer

Author(s) -

Asim Afaq,

Jamshed Bomanji

Publication year - 2018

Publication title -

british medical bulletin

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.08

H-Index - 112

eISSN - 1471-8391

pISSN - 0007-1420

DOI - 10.1093/bmb/ldy032

Subject(s) - medicine , prostate cancer , positron emission tomography , bone scintigraphy , biochemical recurrence , management of prostate cancer , glutamate carboxypeptidase ii , prostate , radiology , cancer , nuclear medicine , prostatectomy

There is an unmet clinical need for early, accurate imaging of recurrent prostate cancer to improve patient outcomes. Staging, by conventional bone scintigraphy and CT have become outdated. 68Ga-PSMA PET/CT imaging in this setting has developed rapidly, with widespread International adoption in line with evidence-based guidelines in this group of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research